Unknown

Dataset Information

0

Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?

ABSTRACT:

SUBMITTER: Costello-Boerrigter LC 

PROVIDER: S-EPMC3447915 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.
| S-EPMC3200240 | biostudies-literature
Unknown Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.
| S-EPMC5440492 | biostudies-literature
Unknown Plant Extracts as Possible Agents for Sequela of Cancer Therapies and Cachexia.
| S-EPMC7555300 | biostudies-literature
Unknown Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin.
| S-EPMC7749591 | biostudies-literature
Unknown Cardiac natriuretic peptides promote adipose 'browning' through mTOR complex-1.
| S-EPMC5870104 | biostudies-other
Unknown Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation.
| S-EPMC6816069 | biostudies-literature
Unknown Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis.
| S-EPMC6915780 | biostudies-literature
Unknown Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective.
| S-EPMC5565993 | biostudies-other
Unknown Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.
| S-EPMC4201035 | biostudies-literature
Unknown Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents.
| S-EPMC5925966 | biostudies-literature